TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Promega Biotech AB
Closing information (x1000 DKK)
Closing information | 2024/03 | 2023/03 | 2022/03 |
Turnover |
62,753
|
58,035
|
59,896 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
8,603
|
8,331
|
4,859 |
EBITDA |
8,652
|
8,438
|
5,019 |
Total assets |
23,839
|
28,220
|
25,037 |
Current assets |
23,739
|
28,077
|
24,784 |
Current liabilities |
8,718
|
6,683
|
9,079 |
Equity capital |
13,165
|
19,770
|
14,406 |
- share capital |
65
|
66
|
72 |
Employees (average) |
10
![]() |
10
![]() |
10 |
Financial ratios
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Solvency |
55.2%
|
70.1%
|
57.5% |
Turnover per employee |
6,275
|
5,804
|
5,990 |
Profit as a percentage of turnover |
13.7%
|
14.4%
|
8.1% |
Return on assets (ROA) |
36.1%
|
29.5%
|
19.4% |
Current ratio |
272.3%
|
420.1%
|
273.0% |
Return on equity (ROE) |
65.3%
|
42.1%
|
33.7% |
Change turnover |
5,902
|
3,039
|
5,448 |
Change turnover % |
10%
|
6%
|
10% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.